Related references
Note: Only part of the references are listed.The recombinant Newcastle disease virus Anhinga strain expressing human TRAIL exhibit antitumor effects on a glioma nude mice model
Jinjiao He et al.
JOURNAL OF MEDICAL VIROLOGY (2021)
Molecular basis and therapeutic implications of CD40/CD40L immune checkpoint
TingTing Tang et al.
PHARMACOLOGY & THERAPEUTICS (2021)
A review of cancer immunotherapy toxicity
Lucy Boyce Kennedy et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
B cells are associated with survival and immunotherapy response in sarcoma
Florent Petitprez et al.
NATURE (2020)
Tertiary lymphoid structures improve immunotherapy and survival in melanoma
Rita Cabrita et al.
NATURE (2020)
B cells and tertiary lymphoid structures promote immunotherapy response
Beth A. Helmink et al.
NATURE (2020)
Intratumoral expression of IL-7 and IL-12 using an oncolytic virus increases systemic sensitivity to immune checkpoint blockade
Shinsuke Nakao et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Ad-CD40L mobilizes CD4 T cells for the treatment of brainstem tumors
Phonphimon Wongthida et al.
NEURO-ONCOLOGY (2020)
Oncolytic Viruses and the Immune System: The Dynamic Duo
Ana Lemos de Matos et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2020)
Oncolytic viruses for cancer immunotherapy
Otto Hemminki et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Design and application of oncolytic viruses for cancer immunotherapy
Erkko Ylosmaki et al.
CURRENT OPINION IN BIOTECHNOLOGY (2020)
The Oncolytic Virus in Cancer Diagnosis and Treatment
Guo-dong Cao et al.
FRONTIERS IN ONCOLOGY (2020)
Herpes Simplex Virus Oncolytic Immunovirotherapy: The Blossoming Branch of Multimodal Therapy
Laura Menotti et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Turning Cold into Hot: Firing up the Tumor Microenvironment
Qianqian Duan et al.
TRENDS IN CANCER (2020)
A tropism-transformed Oncolytic Adenovirus with Dual Capsid Modifications for enhanced Glioblastoma Therapy
Lizheng Wang et al.
JOURNAL OF CANCER (2020)
The TRAIL to cancer therapy: Hindrances and potential solutions
Sonia How Ming Wong et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2019)
Synergistic cancer immunotherapy combines MVA-CD40L induced innate and adaptive immunity with tumor targeting antibodies
Jose Medina-Echeverz et al.
NATURE COMMUNICATIONS (2019)
Targeting the CD40-CD40L pathway in autoimmune diseases: Humoral immunity and beyond
Jodi L. Karnell et al.
ADVANCED DRUG DELIVERY REVIEWS (2019)
Vaccinia virus-mediated cancer immunotherapy: cancer vaccines and oncolytics
Zong Sheng Guo et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Immunology of Adenoviral Vectors in Cancer Therapy
Amanda Rosewell Shaw et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2019)
Developing TRAIL/TRAIL death receptor-based cancer therapies
Xun Yuan et al.
CANCER AND METASTASIS REVIEWS (2018)
CD40L is transferred to antigen-presenting B cells during delivery of T-cell help
Jennifer L. Gardell et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2017)
Adenovirus-mediated CD40L gene transfer increases Teffector/Tregulatory cell ratio and upregulates death receptors in metastatic melanoma patients
A. Schiza et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2017)
The TRAIL-Induced Cancer Secretome Promotes a Tumor-Supportive Immune Microenvironment via CCR2
Torsten Hartwig et al.
MOLECULAR CELL (2017)
Beyond TNF: TNF superfamily cytokines as targets for the treatment of rheumatic diseases
Michael Croft et al.
NATURE REVIEWS RHEUMATOLOGY (2017)
Intratumoral CD40 activation and checkpoint blockade induces T cell-mediated eradication of melanoma in the brain
Manisha Singh et al.
NATURE COMMUNICATIONS (2017)
Intratumoral immunotherapy: using the tumor as the remedy
A. Marabelle et al.
ANNALS OF ONCOLOGY (2017)
Engineered adenovirus fiber shaft fusion homotrimer of soluble TRAIL with enhanced stability and antitumor activity
J. Yan et al.
CELL DEATH & DISEASE (2016)
A novel capsid-modified oncolytic recombinant adenovirus type 5 for tumor-targeting gene therapy by intravenous route
Zhen Wang et al.
ONCOTARGET (2016)
Cancer immunotherapy: harnessing the immune system to battle cancer
Yiping Yang
JOURNAL OF CLINICAL INVESTIGATION (2015)
Oncolytic viruses: a new class of immunotherapy drugs
Howard L. Kaufman et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
Intratumoral oncolytic adenoviral treatment modulates the glioma microenvironment and facilitates systemic tumor-antigen-specific T cell therapy
Jian Qiao et al.
ONCOIMMUNOLOGY (2015)
ER stress regulates myeloid-derived suppressor cell fate through TRAIL-R-mediated apoptosis
Thomas Condamine et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
TRAIL suppresses tumor growth in mice by inducing tumor-infiltrating CD4+CD25+ Treg apoptosis
Zhijuan Diao et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
Effective Treatment of an Orthotopic Xenograft Model of Human Glioblastoma Using an EGFR-retargeted Oncolytic Herpes Simplex Virus
Hiroaki Uchida et al.
MOLECULAR THERAPY (2013)
Failure of Translation of Human Adenovirus mRNA in Murine Cancer Cells Can be Partially Overcome by L4-100K Expression In Vitro and In Vivo
Anna-Mary Young et al.
MOLECULAR THERAPY (2012)
TRAIL gene-armed oncolytic poxvirus and oxaliplatin can work synergistically against colorectal cancer
M. F. Ziauddin et al.
GENE THERAPY (2010)
The TRAIL apoptotic pathway in cancer onset, progression and therapy
Ricky W. Johnstone et al.
NATURE REVIEWS CANCER (2008)
CD154 induces p73 to overcome the resistance to apoptosis of chronic lymphocytic leukemia cells lacking functional p53
Frank Dicker et al.
BLOOD (2006)
Fas-ligand (CD178) and TRAIL synergistically induce apoptosis of CD40-activated chronic lymphocytic leukemia B cells
F Dicker et al.
BLOOD (2005)
Evaluation of accuracy and precision of adenovirus absorptivity at 260 nm under conditions of complete DNA disruption
JA Sweeney et al.
VIROLOGY (2002)
Share Paper
